Center for Clinical and Basic Research ASRegistered
Key figures
566 390 €−46,8%
Revenue 2025
+9,6%
Average annual growth 2019–2025
Ratios
2025−23,0%
Profit margin
−23,4%
EBITDA margin
96,1%
Equity ratio
18×
Current ratio
−26,5%
Return on equity
1622 €
Average gross salary
Profit exceeds EBITDA because of financial income (e.g. dividends or interest), which EBITDA does not include.
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 178 718 € | 17 | 42 209 € |
| Q1 2026 | 216 089 € | 17 | 44 098 € |
| Q4 2025 | 160 564 € | 17 | 45 796 € |
| Q3 2025 | 154 024 € | 17 | 45 068 € |
| Q2 2025 | 105 000 € | 16 | 43 816 € |
| Q1 2025 | 303 025 € | 16 | 43 363 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculated2025
No dividends were distributed.
History
20250 €
20240 €
20230 €
20220 €
20213 160 168 €
20200 €
Previous year's retained earnings + previous year's profit − current retained earnings.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 5 937 976 | 5 505 347 | 320 676 | 281 256 | 128 264 | 478 955 | 361 856 |
| Total non-current assets | 3257 | 2549 | 1841 | 14 204 | 233 398 | 162 355 | 148 983 |
| Total assets | 5 941 233 | 5 507 896 | 322 517 | 295 460 | 361 662 | 641 310 | 510 839 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 1 106 521 | 1 151 113 | 28 106 | 28 875 | 25 399 | 20 454 | 20 163 |
| Non-current liabilities | 113 103 | 113 103 | 0 | — | — | — | — |
| Total liabilities | 1 219 624 | 1 264 216 | 28 106 | 28 875 | 25 399 | 20 454 | 20 163 |
| Share capital | 25 565 | 25 565 | 25 565 | 25 560 | 25 560 | 25 560 | 25 560 |
| Retained earnings of previous periods | 5 131 657 | 4 693 488 | 1 055 391 | 266 295 | 238 469 | 308 147 | 592 740 |
| Profit for the year | −438 169 | −477 929 | −789 101 | −27 826 | 69 678 | 284 593 | −130 180 |
| Reserves and other equity | 2556 | 2556 | 2556 | 2556 | 2556 | 2556 | 2556 |
| Total equity | 4 721 609 | 4 243 680 | 294 411 | 266 585 | 336 263 | 620 856 | 490 676 |
| Income statement | |||||||
| Sales revenue | 325 891 | 142 334 | 256 073 | 700 551 | 840 850 | 1 063 890 | 566 390 |
| Operating profit | −574 881 | −510 781 | −26 929 | −27 838 | 69 512 | 276 944 | −137 351 |
| EBITDA | −574 608 | −510 073 | −26 221 | −26 308 | 73 140 | 280 804 | −132 287 |
| Profit before income tax | −438 169 | −477 929 | 1591 | −27 826 | 69 678 | 284 593 | −130 180 |
| Profit for the reporting year | −438 169 | −477 929 | −789 101 | −27 826 | 69 678 | 284 593 | −130 180 |
| Labour costs | 634 582 | 512 935 | 334 176 | 368 317 | 388 256 | 395 446 | 397 942 |
| Depreciation of non-current assets | 273 | 708 | 708 | 1530 | 3628 | 3860 | 5064 |
| Other indicators | |||||||
| Employees | 14 | 13 | 13 | 15 | 16 | 16 | 14 |
| Calculated dividend | — | 0 | 3 160 168 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Research and development in natural sciences and engineering